Publication | Closed Access

Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist

Study DesignMedicineInterleukin-1 Receptor AntagonistImmunologyPopulation Pharmacokinetic AnalysisPharmacotherapyImmunotherapyPharmacologyPhysiologically-based Pharmacokinetic ModelingPharmacokineticsPharmacodynamic ModelingQuantitative Pharmacology